Michelle Barnes

TL;DR: It was found that few studies of the 2009 influenza pandemic reported on bacterial complications and testing, and secondary bacterial infection was identified in almost one in four patients, with Streptococcus pneumoniae the most common bacteria identified.

TL;DR: The estimated vaccine effectiveness against AMI was comparable with the efficacy of currently accepted therapies for secondary prevention of AMI from clinical trial data, and a large-scale randomised controlled trial is needed to provide robust evidence of the protective effect of influenza vaccination on AMI.

TL;DR: Influenza vaccine should be considered as an integral part of CVD management and prevention and incorporated into routine CVD prevention in patient care requires a clinical practice paradigm change.

TL;DR: There is a need for more research on persistence, and a uniform approach to infection control guidelines in convalescence, as available evidence suggests that EBOV can persist in some body fluids after clinical recovery and clearance of virus from the blood.

TL;DR: Immunosuppressed children had an adequate immunogenic response to Quadrivalent HPV vaccine regardless of age and the cause of immunosuppression, so early vaccination and optimal scheduling should be further studied in such children.